Birdwatch Note Rating
2023-05-24 16:52:49 UTC - NOT_HELPFUL
Rated by Participant: 1D6BCF3EC5BD185718B3B9C72EDCB03A3CA0446941D34D4B83E574C2E6F6370E
Participant Details
Original Note:
Following publication of new data from a clinical trial looking at the outcome of admission to hospital, WHO has updated its recommendation. WHO now suggests the use of Remdesivir in mild or moderate COVID-19 patients who are at high risk of hospitalization. https://www.who.int/news/item/22-04-2022-who-recommends-highly-successful-covid-19-therapy-and-calls-for-wide-geographical-distribution-and-transparency-from-originator
All Note Details